Results showed that the expressions of myocardial hypertrophy-related genes and proteins including ANP, BNP and β-MHC were markedly up-regulated in Ang II-treated cardiomyocytes compared with control group (Figures 1A,B,C,E). The gene discussed is NPPA; the disease is hypertrophy.